Consistent with these findings, lymph node-colonizing melanoma cells demonstrated increased sensitivity to RSL3 compared with their parental counterparts, which correlated with decreased intracellular levels of GPX4-relevant metabolites, notably glutathione.1 This evidence concerns the gene GPX4 and melanoma.